BioPhausia (OTC products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

BioPhausia (OTC products) General Information

Description

A portfolio of OTC products comprising of novalucol, novalucid, c-vimin and resulax brands.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Blasieholmsgatan 2
  • 111 48 Stockholm
  • Sweden
Primary Industry
Buildings and Property
Other Industries
Other Commercial Products
Pharmaceuticals
Acquirer
Meda
Corporate Office
  • Blasieholmsgatan 2
  • 111 48 Stockholm
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPhausia (OTC products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioPhausia (OTC products)‘s full profile, request access.

Request a free trial

BioPhausia (OTC products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioPhausia (OTC products)‘s full profile, request access.

Request a free trial

BioPhausia (OTC products) FAQs

  • Where is BioPhausia (OTC products) headquartered?

    BioPhausia (OTC products) is headquartered in Stockholm, Sweden.

  • What industry is BioPhausia (OTC products) in?

    BioPhausia (OTC products)’s primary industry is Buildings and Property.

  • Is BioPhausia (OTC products) a private or public company?

    BioPhausia (OTC products) is a Private company.

  • What is the current valuation of BioPhausia (OTC products)?

    The current valuation of BioPhausia (OTC products) is .

  • What is BioPhausia (OTC products)’s current revenue?

    The current revenue for BioPhausia (OTC products) is .

  • Who are BioPhausia (OTC products)’s investors?

    BioPhausia has invested in BioPhausia (OTC products).

  • When was BioPhausia (OTC products) acquired?

    BioPhausia (OTC products) was acquired on 23-Sep-2010.

  • Who acquired BioPhausia (OTC products)?

    BioPhausia (OTC products) was acquired by Meda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »